AMPK reverses the mesenchymal phenotype of cancer cells by targeting the Akt-MDM2-Foxo3a signaling axis.

Chou CC, Lee KH, Lai IL, Wang D, Mo X, Kulp SK, Shapiro CL, Chen CS

Open source

DOI
10.1158/0008-5472.can-14-0135
Published
2014 Sep 1
Container
Cancer research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 39/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/0008-5472.can-14-0135,
  title = {AMPK reverses the mesenchymal phenotype of cancer cells by targeting the Akt-MDM2-Foxo3a signaling axis.},
  author = {Chou CC and Lee KH and Lai IL and Wang D and Mo X and Kulp SK and Shapiro CL and Chen CS},
  year = {2014},
  journal = {Cancer research},
  doi = {10.1158/0008-5472.can-14-0135},
  url = {https://doi.org/10.1158/0008-5472.can-14-0135}
}

RIS

TY  - JOUR
TI  - AMPK reverses the mesenchymal phenotype of cancer cells by targeting the Akt-MDM2-Foxo3a signaling axis.
AU  - Chou CC
AU  - Lee KH
AU  - Lai IL
AU  - Wang D
AU  - Mo X
AU  - Kulp SK
AU  - Shapiro CL
AU  - Chen CS
PY  - 2014
JO  - Cancer research
DO  - 10.1158/0008-5472.can-14-0135
UR  - https://doi.org/10.1158/0008-5472.can-14-0135
ER  - 

APA

CC, C., KH, L., IL, L., D, W., X, M., SK, K., CL, S., & CS, C. (2014). AMPK reverses the mesenchymal phenotype of cancer cells by targeting the Akt-MDM2-Foxo3a signaling axis.. Cancer research. https://doi.org/10.1158/0008-5472.can-14-0135

Source records